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Summary
Nodal/activin signaling plays a key role in anterior-posterior
(A-P) axis formation by inducing the anterior visceral endo-
derm (AVE), the extraembryonic signaling center that initi-
ates anterior patterning in the embryo. Here we provide
direct evidence that the mitogen-activated protein kinase
(MAPK) p38 regulates AVE specification through a crosstalk
with the Nodal/activin signaling pathway. We show that p38
activation is directly stimulated by Nodal/activin and fails to
be maintained upon inhibition of this pathway both in vivo
and in vitro. In turn, p38 strengthens the Nodal signaling
response by phosphorylating the Smad2 linker region and
enhancing the level of Smad2 activation. Furthermore, we
demonstrate that this p38 amplification loop is essential
for correct specification of the AVE in two ways: first, by
showing that inhibiting p38 activity in 5.5 days postcoitum
embryo cultures leads to a switch from AVE to an extraem-
bryonic visceral endoderm cell identity, and second, by
demonstrating that genetically reducing p38 activity in
a Nodal-sensitive background leads to a failure of AVE spec-
ification in vivo. Collectively, our results reveal a novel role
for p38 in regulating the threshold of Nodal signaling and
propose a new mechanism by which A-P axis development
can be reinforced during early embryogenesis.
Results and Discussion
P38 Is Required for the Specification of the Anterior
Visceral Endoderm
The anterior-posterior (A-P) axis of the mammalian embryo is
the first of the definitive embryonic axes to be determined.
The A-P axis is initiated by the induction of the anterior visceral
endoderm (AVE) at the distal tip of the 5.5 days postcoitum
(dpc) embryo and its migration to the prospective anterior of
the embryo shortly after [1, 2]. Nodal signaling from the
epiblast is thought to induce the AVE by promoting AVE-
specific gene expression and by blocking inhibitory BMP
signals secreted by the extraembryonic ectoderm [3–5]. It is
not understood what other players are important for specifica-
tion of the AVE or how the Nodal signals are interpreted within
the visceral endoderm.
To analyze the role of the p38MAPK in AVE specification, we
used SB203580, a specific inhibitor of the p38a and b [6], which
has been used to analyze p38 function during preimplantation
development [7, 8] and gastrulation [9]. When 5.5 dpc embryos
were cultured overnight in the presence of SB203580, we
observed that the expression of the AVE reporter Hex-GFP*Correspondence: tristan.rodriguez@csc.mrc.ac.uk[10] was restricted to the distal tip of the embryo (see Fig-
ure S1A available online) and the expression of the AVE
markers Lim1, Hex, Dkk1, and Lefty1/2 was completely lost
(Figures 1A–1D). In contrast, Bmp2 expression could still
be observed (Figure 1E) and the expression of the extraembry-
onic visceral endoderm markers Hnf4, Ttr, and Gata4 were
clearly expanded into the embryonic visceral endoderm (Fig-
ures 1F–1H0). Similar results were obtained with SB220025,
a second specific inhibitor of p38a and b activity [11] (data
not shown). Expression of the pluripotent epiblast marker
Oct4 and the trophoblast stem cell marker Errb remained
unchanged after overnight treatment of 5.5 dpc embryos
with SB203580 (data not shown), and the expression of meso-
derm patterning markers Eomes, Fgf8, T, and Snail was not
diminished when 6.5 dpc embryos were cultured overnight in
the presence of the p38 inhibitor (Figures 1L–1O). This
suggests that inhibition of p38 is specifically affecting AVE
specification.
To test whether p38 has a direct effect on AVE gene expres-
sion, we treated 5.5 dpc embryos with SB203580 for 4 hr.
Within this time window, the expression of Lim1 and Lefty1/2
was lost (Figures 1I and 1J), whereas the expression of
Bmp2 could still be observed in these embryos (Figure 1K).
These results suggest that p38 is directly regulating the
expression of a subset of AVE genes.
Nodal Signaling Lies Upstream of p38 Phosphorylation
in the Visceral Endoderm
Given the requirement for p38 activity for the correct specifica-
tion of the AVE, the site of active p38 in the early embryo was
investigated. At 5.0–5.5 dpc, expression of the phosphorylated
(activated) form of p38 (p-p38) was highest in the cytoplasm of
visceral endoderm cells, with some of these cells also showing
nuclear localization. Weak expression was also observed in
the cytoplasm of epiblast cells at these stages (Figures 2A
and 2B). At 5.5 dpc, along with the visceral endoderm expres-
sion, mitotic cells of the epiblast were also strongly labeled by
the anti-p-p38 antibody. At 6.5 dpc, this pattern was main-
tained, although a downregulation in the levels of p-p38 was
observed within the cells of the visceral endoderm (Figure 2C).
This data is consistent with a direct role for p38 in regulating
AVE gene expression.
The main signaling pathway that has been shown to be
responsible for AVE specification is the Nodal pathway [3].
We analyzed the expression of p-p38 in mutants for Nodal
[12] and for the Nodal coreceptor Cripto [13] and found that
although at 4.5 dpc the distribution of p-p38 was not signifi-
cantly different between control and Nodal mutant embryos,
p38 phosphorylation was severely downregulated or lost in
both Nodal and Cripto mutants at 5.5 dpc (Figures 2D–2F0),
indicating that Nodal signaling is required for p38 activation
at this stage.
To further examine the requirement for Nodal activation of
p38 phosphorylation, we turned to extraembryonic endoderm
(XEN) cells, which are primitive endoderm stem cells and
provide an in vitro model for extraembryonic endoderm devel-
opment [14]. XEN cells were treated for up to 1 hr with either
the TGF-b factor activin, which is also required for AVE
Figure 1. p38 Activity Is Required for AVE Induction
(A–E) Expression of Lim1,Hex, Lefty1/2, andDkk1 is lost, but Bmp2 expression is unaffected in 5.5 days postcoitum (dpc) embryos cultured overnight (O/N)
in the presence of the p38 inhibitor SB203580 (n = 25, 25, 22, 25, and 32 for SB203580 treated and 19, 20, 23, 19, and 24 for controls).
(F–J) The expression of the extraembryonic visceral endodermmarkersHnf4, Ttr, andGata4 is expanded into the embryonic visceral endoderm region after
p38 inhibition in overnight cultures of 5.5 dpc embryos (n = 14, 13, and 13 for SB203580 treated and 14, 13, and 15 for controls; horizontal lines indicate the
level of cross-sections shown in F0, G0, and H0).
(F0–H0) Transverse sections of embryos analyzed for Hnf4, Ttr, and Gata4 expression indicating a proximal expansion in the expression of these genes after
p38 inhibition.
(I–K) Inhibition for 4 hr of p38 activity in 5.5 dpc embryos abolishes Lim1 and Lefty1/2 expression but does not affect Bmp2 expression (n = 8, 6, and 9 for
SB203580 treated and 7, 7, and 6 for controls).
(L–O) Expression of Eomes, Fgf8, T, and Snail is not decreased in overnight cultures (O/N) of 6.5 dpc embryos after p38 inhibition (n = 39, 20, 24, and 20 for
SB203580 treated and 22, 18, 16, and 13 for controls).
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clearly indicated that activin was capable of stimulating p38
phosphorylation within 5 min of treatment (Figure 2G). In
contrast, BMP4 did not produce any increase in the levels of
p38 phosphorylation (Figure 2H). Immunofluorescence also
indicated that XEN cells responded to a 30 min treatment
with activin, Nodal, or the Nodal coreceptor Cripto by stimula-
tion of p38 phosphorylation (Figure 2I). This activation of p38
was dependent on its autocatalytic activity because it could
be blocked using SB203580 (Figure 2J). The stimulation of
p38 phosphorylation by Cripto is likely to be independent of
Nodal, because this factor is not expressed in XEN cells
(Figure S1G). We also observed that the activation of p38 by
activin is not dependent on Alk4, 5, or 7, the type I receptors
for Nodal/activin signaling, because inhibition of these recep-
tors with SB431542 did not block p38 phosphorylation in XEN
cells (Figure S1E). The findings that p38 phosphorylation can
be triggered by Cripto in XEN cells and require Cripto in vivo
but are not dependent on the type I TGF-b receptors indicate
that Cripto plays a crucial role in p38 activation. Together,
these results suggest that in the visceral endoderm, Nodal
and activin are ligands that stimulate p38 activation during
AVE specification and that this activation is amplified by
autophosphorylation of p38.
p38 Is Required for Maximal Nodal Signaling
We next set out to establish how p38 was affecting AVE gene
expression. We asked whether p38 inhibition affected theactivation of Smad2, the effector of canonical Nodal/activin
signaling [15]. XEN cells were treated for 30 min with activin
or Nodal in the presence of SB203580 and the levels of phos-
phorylated Smad2 (p-Smad2) were determined. We observed
that p38 inhibition drastically reduced the overall activation by
Nodal/activin of p-Smad2 and its translocation to the nucleus
(Figures 3A and 3B; Figure S2F). By titrating the concentration
of inhibitor used to block p38, we observed that there was
a direct correlation between the levels of p-p38 and the levels
of p-Smad2 (Figure S2). In contrast to this treatment, p38
inhibition did not affect the overall levels of Smad2, the levels
of activation of Smad1/5/8 by BMP signaling, or the levels of
activation of Erk1/2 by Fgf signaling (Figures S1B–S1D).
Knocking down p38a in XEN cells using siRNA caused a 1.9-
fold reduction in p38 protein and a corresponding 3.2-fold
reduction in the proportion of cells showing Smad2 activation
(Figure S3), confirming the specificity of the results obtained
using the inhibitor. Together, these results indicate that p38
signaling is required to enhance Smad2 activation.
To analyze whether p38 inhibition also affected Smad2
target gene expression, we analyzed how p38 inhibition
affected stimulation by activin of the Smad2 responsive
element SBE4 [16]. This reporter contains four repeats of the
Smad2 DNA binding element driving the expression of lucif-
erase. In transient transfection assays in XEN cells, we
observed that activin could efficiently stimulate expression
of this reporter, whereas p38 inhibition significantly reduced
this stimulation, and inhibition of the Alk4/5/7 receptors with
Figure 2. Nodal Signaling Activates p38
(A–C) Immunostaining showing that phosphorylated p38 (p-p38) is present at highest levels within the visceral endoderm between 5.0 and 6.5 dpc embryos
but is also activated at high levels in mitotic cells of the epiblast from 5.5 dpc. Weak expression is observed in the epiblast at these stages.
(D–F0) p-p38 expression is not affected at 4.5 dpc (D and D0) but is lost in Nodal (E and E0) and Cripto (F and F0) mutants at 5.5 dpc.
(G and H) Western blot showing that activin can stimulate p38 phosphorylation within 5 min in XEN cells (G) but BMP4 cannot (H).
(I) Immunofluorescence showing that activin, Nodal, and Cripto can stimulate p-p38 in XEN cells.
(J) Inhibition of p38 activity by SB203580 decreases p-p38 stimulation, indicating that p38 autophosphorylation is required to enhance p38 activity.
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1291SB43154 completely abolished it (Figure 3C). This demon-
strates that p38 activity is also required for correct activation
of the Nodal/activin target genes.
Next we analyzed whether p38 controls AVE specification
by modulating Nodal/activin signaling. For this we cultured
5.5 dpc embryos overnight in the presence of the p38 inhibitor
alone or with 100 ng/ml of activin. We observed that, asdescribed in Figure 1, in those embryos treated with the p38
inhibitor, the expression of the AVE markers Dkk1 and Lim1
was completely abolished. In contrast to this, in embryos
treated with the p38 inhibitor plus activin there was a partial
rescue of the expression of these genes. In p38 inhibitor plus
activin-treated embryos, although the expression Dkk1 and
Lim1 was weaker than in controls and had not migrated toFigure 3. p38 Is Required for Maximal Nodal
Signaling
(A and B) Immunofluoresence showing that inhi-
bition of p38 activity decreases the level of
C-terminal Smad2/3 phosphorylation by activin
(A) and western blot showing that inhibition of
p38 activity decreases the level of C-terminal
Smad2 phosphorylation by activin in XEN
cells (B).
(C) Luciferase assays show that inhibiting p38
activity decreases the level of stimulation by
activin of the Smad2 responsive element SBE4
in XEN cells. Graph is the mean relative expres-
sion of two replicate experiments. Results are
mean 6 standard error of the mean of triplicate
samples expressed relative to control untreated
samples. *p < 0.05; **p < 0.001.
(D) Expression of Dkk1 and Lim1 is partially
rescued by activin in 5.5 dpc embryos cultured
overnight with p38 inhibitors (n = 6 and 6 for
control, 9 and 8 for activin alone, 9 and 10 for
SB203580, and 10 and 10 for SB203580+activin).
Figure 4. p38 Affects the Levels of Activation of Smad2
(A) Western blot showing that activin stimulates p38-dependent phosphorylation of the Smad2 linker region in XEN cells.
(B) p38 inhibition can decrease C-terminal p-Smad2 phosphorylation levels even in the presence of the proteasome inhibitor MG132 and does not prolong
the length of Smad2 signaling. Cells were pretreated with activin for 30 min, and then the decay of Smad2 C-terminal phosphorylation was analyzed in the
presence of the type I TGF-b receptor SB431542 and in the presence or absence of the p38 inhibitor and MG132 in XEN cells.
(C) Time course and quantification of activin treatment in the presence or absence of the p38 inhibitor SB203580 and of the type I TGF-b receptor inhibitor
SB431542 in XEN cells show that p38 inhibition decreases activation of Smad2 C-terminal phosphorylation as early as 5 min after activin stimulation. Graph
is representative of three experiments.
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1293the prospective anterior, the expression of these genes could
be clearly observed at the distal tip of the embryo (Figure 3D).
This data indicates that during AVE specification p38
enhances Nodal/activin signaling but also suggests that in
addition to this role, p38 is likely to have roles that are indepen-
dent of Nodal/activin signaling.
The observations that p38 is required for maximal levels of
Smad2 phosphorylation and for proper Nodal/activin target
gene expression, together with the finding that p38 acts down-
stream of Nodal/activin, argue that p38 acts in a positive
amplification loop for Nodal signaling.
Smad2 Activation Is Regulated by p38
How is p38 enhancing Nodal signaling? The linker region of
Smad2 contains four MAPK phosphorylation sites [17]; there-
fore, we tested whether Nodal/activin signaling led to the
phosphorylation of these linker region sites. We observed
that activin increased Smad2 linker region phosphorylation
(Figure 4A) and that this phosphorylation was dependent on
p38 activity, because inhibition by SB203580 led to a clear
reduction in linker region phosphorylation (Figure 4A). This
was most obvious after 30 min of activin treatment but could
also be observed after 60 min of treatment. Therefore, activin
via p38 caused the phosphorylation of the Smad2 linker
region.
We next set out to establish at which step of the activin
signaling pathway p38 is affecting Smad2 phosphorylation.
Two ways in which p38 could alter Smad2 activity are by
altering its rate of signaling termination or its signaling activa-
tion rate. That is, p38 could be decreasing the rate of p-Smad2
degradation or increasing the levels of p-Smad2 phosphory-
lation by the receptor complex. The rate of termination of
Smad2 signaling can be affected in two ways, by degradation
via the proteasome or by dephosphorylation by phosphatases
(reviewed by [15, 18]). We analyzed whether p38 could be
protecting p-Smad2 from either of these two mechanisms.
XEN cells were stimulated for 30 min with activin and then
signaling was blocked using the TGF-b receptor inhibitor
SB431542 and the decay of C-terminal p-Smad2 was
analyzed in the presence or absence of proteasome inhibitors
(MG132 or lactacystin), a pan-phosphatase inhibitor or oka-
daic acid, an inhibitor of the PPP phosphatases that specifi-
cally act on Smad2 [19]. MG132, lactacystin, and okadaic
acid caused a clear accumulation of C-terminal phosphory-
lated Smad2 after activin stimulation (Figure 4B; Figures
S4A–S4C), indicating that degradation and dephosphorylation
are regulating the overall levels of C-terminal Smad2 phos-
phorylation in XEN cells. We then analyzed whether p38
inhibition still caused a decrease in p-Smad2 levels in the
presence of protease or phosphatase inhibition. We observed
that inhibiting p38 activity in the presence of MG132, lactacys-
tin, the pan-phosphatase inhibitor, or okadaic acid still led to
a decrease in p-Smad2 phosphorylation (Figure 4B; Figures
S4A–S4C), suggesting that p38 is affecting p-Smad2 levels
independent of degradation via the proteasome or of phos-
phatase activity.
The fact that p38 isworking independently of the termination
of p-Smad2 signaling suggests that it must be acting upstream(D) Transfection of XEN cells with Flag-Smad2 or Flag-Smad2EPSM and imm
showing nuclear or cytoplasmic expression of Smad2. Mutation of the MAPK b
activin stimulation.
(E) Lim1 expression at 5.0 dpc and Lim1, Lefty1/2, and Cerl1 expression at 6.5
14/14, 11/11, and 2/2) but are reduced or lost in p38IP2/2; Nodal+/2 embryos (of these events. For this reason we analyzed whether p38 is
affecting the rate of Smad2 activation by carrying out a time
course of Smad2 activation kinetics in response to activin
treatment and analyzing how this is affected by p38 inhibition.
We observed that phosphorylation of Smad2 is stimulated
as early as 5 min after activin treatment and that even at
this early time point, p38 inhibition reduces the overall level
of C-terminal p-Smad2 (Figure 4C). This indicates that p38 is
affecting the rate of Smad2 activation and therefore it is at
this step of the Nodal/activin signaling pathway that p38 is
acting.
We next tested what the impact of phosphorylation of the
Smad2 linker region by p38 MAPK has on the Smad2 signaling
activation. For this we used a Flag-tagged Smad2 construct
where the MAPK linker region phosphorylation sites have
been mutated (Flag-Smad2EPSM) [20]. A critical step that
occurs after Smad2 activation is its translocation to the
nucleus. When we analyzed whether there was any difference
in the translocation to the nucleus of Flag-Smad2EPSM with
respect to Flag-Smad2, we found that although Flag-Smad2
showed efficient nuclear localization after activin stimulation
(55% cells with nuclear Flag-Smad2; Figure 4D; Figure S5D),
mutation of the MAPK phosphorylation sites in Smad2 nearly
completely abolished this nuclear translocation (7% cells
with nuclear Flag-Smad2EPSM; Figure 4D; Figure S4E). Similar
results were observed when cells were transfected with the
wild-type Flag-Smad2 and stimulated with activin in the
presence of the p38 inhibitor (8% cells with nuclear Flag-
Smad2; Figure 4D). These results demonstrate that p38
phosphorylation of the Smad2 linker region is essential for
correct nuclear localization of Smad2 and to achieve high
levels of Nodal/activin signaling.
Mutation of p38IP in a Nodal-Sensitive Background Leads
to a Failure to Specify the AVE
Given that we have found that p38 is critical to achieve
maximal Nodal signaling, we set out to test this requirement
genetically and in vivo. p38IP is a p38 interacting protein
required for p38 activity and mesoderm migration during
early mouse development [9]. Little is known as to how
p38IP regulates p38 function and p38IP embryos correctly
establish an A-P axis and specify an AVE ([9]; Figure 4). We
tested whether lowering the threshold of Nodal signaling in
p38IP-depleted background would affect AVE specification
by generating embryos homozygous for a mutation in p38IP
[9] and heterozygous for a Nodal null allele [12]. When we
analyzed the expression of the AVE markers Lim1 at 5.5
dpc and Lim1, Cerl1, and Lefty1 at 6.5 dpc, in either control
embryos or p38IP2/2 embryos, we observed that all three
genes are appropriately expressed (Figure 4E). In contrast
to this in p38IP2/2; Nodal+/2 embryos, the expression of all
three AVE markers is completely lost or severely reduced in
the majority of embryos analyzed (20 out of 21 embryos),
showing that p38 and Nodal cooperate during AVE specifica-
tion. These results indicate that p38 activity is required to
enhance Nodal signaling in the embryo and therefore that
the crosstalk between p38 and Nodal signaling is essential
to establish the A-P axis during mouse development.unofluorescence against the Flag tag and a plot of the percentage of cells
inding sites in the linker region of Smad2 inhibits nuclear accumulation after
dpc are observed in the AVE of control and p38IP mutant embryos (n = 5/5,
n = 6/7, 11/11, 2/2, and 1/1).
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Graded Nodal signaling is central to axis specification in the
vertebrateembryo,andhowthedifferent thresholdsofsignaling
are achieved determines what cell identity is specified by this
pathway. At the time that the AVE is induced, high levels of
expression of extracellular and intracellular inhibitors of Nodal
signaling that modulate A-P axis specification have been re-
ported [4, 21, 22]. However, no positive amplification signals
that ensure that high levels of Nodal signaling are achieved
in the embryo at this stagehavebeendescribed.Wehave found
that in the early embryo there is a crosstalk between p38 and
the Nodal signaling pathway that enhances Nodal signaling.
This crosstalk is essential for AVE induction and therefore
for establishment of the A-P axis of the mouse embryo.
Our data suggest that the interaction between p38 and the
Nodal/activin signaling pathways occurs at least at two levels.
First, the TGF-b ligands Nodal/activin aswell as the coreceptor
Cripto can stimulate p38 phosphorylation and therefore acti-
vate this MAPK. Second, p38 in turn enhances Nodal/activin
signaling within the visceral endoderm via phosphorylation
of the Smad2 linker region to ensure maximal activation of
Smad2. These results contrast with those for BMP signaling
where MAPK and GSK3b phosphorylation of the Smad1 linker
region decreases Smad1 stability and leads to a shorter dura-
tion of BMP signaling [17, 23]. How do we account for these
differences? In the case of BMP signaling, the Smad1 linker
region is phosphorylated by MAPK and GSK3b. In this case,
the MAPK phosphorylation event serves as a primer for phos-
phorylation of the GSK3b sites [17, 23]. However, in the case of
Smad2, no consensus phosphorylation sites for GSK3b exist
within its linker region, and only MAPK sites can be found
[15, 17]. This suggests that for Smad2, the phosphorylated
MAPK sites present within its linker region do not act as
primers for GSK3b phosphorylation but have a different role.
We propose that by phosphorylating the Smad2 linker region,
p38 increases Smad2 activation by altering its affinity either to
the TGF-b receptors or to negative regulators of this pathway,
such as Smad7, resulting in higher levels of p-Smad2 and
therefore higher levels of Nodal/activin signaling.
Could this interaction have any relevance to other contexts
where Nodal signaling is required? During gastrulation, the
posterior epiblast cells undergo an epithelial to mesenchymal
transition (EMT) that is essential for proper mesoderm migra-
tion from the primitive streak. Both p38IP and p38 have been
shown to be required to downregulate e-cadherin in the prim-
itive streak and therefore are essential for proper mesoderm
migration to occur [9]. Nodal signaling has also been proposed
to regulate EMT and control the downregulation of e-cadherin
during mesoderm migration [2, 24], and we find that p38IP
and Nodal genetically interact. It is therefore possible that
the Nodal/p38 amplification loop may also be acting during
gastrulation in the mouse embryo. In the sea urchin embryo,
p38 has been shown to control Nodal expression and in this
way regulate the establishment of the dorsoventral axis [25].
This suggests that the involvement of p38 in amplifying Nodal
signaling may be evolutionarily conserved.
In conclusion, our work sheds light on how different thresh-
olds of Nodal signaling are achieved within the embryo and on
the consequences that these different thresholds have on cell
fate decisions during early embryonic development. From
a broader perspective, this work highlights a novel mechanism
that enhances TGF-b signaling and therefore has important
implications for the regulation of this pathway in development
and disease.Supplemental Information
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